According to a study, miR-424 may inhibit cell growth and arrest in cell cycle phases (particularly G2/M) in human breast cancer by negatively regulating cyclin-dependent kinase 1 (CDK1) mRNA, which may occur via the Hippo and ERK pathways.84 Here, CDK1 is linked to breast carcinoma.